Published 1 day ago • loading... • Updated 1 day ago
Start-up Biotech The Cat Health Company, Funded by Early Game Ventures: We Have Clinically Validated the First Treatment for Feline Longevity and Signed a European Distribution Agreement with Vetro
The Start-up of Biotechnology The Cat Health Company (TCHC), which develops therapies to increase feline longevity and has previously attracted funding of over $1.7 million from the local Early Game Ventures fund and international profile investors (such as Portfolio, 100 Plus Capital and founder Insilico Medicine), has completed a European multi-centre clinical study and signed the first licensing, production and distribution partnership with t…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
The Start-up of Biotechnology The Cat Health Company (TCHC), which develops therapies to increase feline longevity and has previously attracted funding of over $1.7 million from the local Early Game Ventures fund and international profile investors (such as Portfolio, 100 Plus Capital and founder Insilico Medicine), has completed a European multi-centre clinical study and signed the first licensing, production and distribution partnership with t…